Emergency Medicine Doctors in Delano, CA Accepting Medicare

6 Emergency Medicine doctors found. Showing 1 - 6

Milton Kamansky, PA-C Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1401 Garces Hwy, Delano, CA 93215 Phone: 661-721-5252

Ramana V Kumar, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1401 Garces Highway, Delano, CA 93215 Phone: 661-721-5262    Fax: 661-721-5254

Gulshanjit Kaur Dhaliwal, PA Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1401 Garces Hwy, Delano, CA 93215 Phone: 661-725-4800

Dr. Marcus F. Lee, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1401 Garces Highway, Delano, CA 93215 Phone: 661-721-5262    Fax: 661-721-5254

Dr. Sam J. Shields, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1401 Garces Highway, Delano, CA 93215 Phone: 661-721-5262    Fax: 661-721-5254

Malcolm Bruce Parker Iii, Emergency Medicine - Emergency Medical Services Medicare: Medicare Enrolled Practice Location: 1401 Garces Hwy, Delano, CA 93215 Phone: 661-725-4800

News Archive

Researchers explore new strategy to defeat drug-resistant strains of malaria

Malaria is one of the most deadly infectious diseases in the world today, claiming the lives of over half a million people every year, and the recent emergence of parasites resistant to current treatments threatens to undermine efforts to control the disease. Researchers are now onto a new strategy to defeat drug-resistant strains of the parasite. Their report appears in the journal ACS Chemical Biology.

Virginia Tech and UC San Diego researchers team up to develop nonopioid drug for chronic pain

Researchers from the Virginia Tech School of Neuroscience are teaming with the University of California San Diego and the U.S. National Institutes of Health to develop a drug - now in its earliest stages - that can treat certain types of chronic pain without the addictive consequences of opioids.

First-line dacomitinib may improve advanced NSCLC survival

Preliminary research suggests that the second-generation tyrosine kinase inhibitor dacomitinib may improve progression-free survival in patients with advanced non-small-cell lung cancer with epidermal growth factor receptor mutations.

Hydrophobic proteins may serve as biomarkers for treating colorectal cancer

Colorectal cancer, cancer of the colon and rectum, is a common cause of mortality worldwide. Statistical data showed that the number of deaths caused by colorectal cancer is increasing in both men and women.

Read more Medical News

› Verified 6 days ago